We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Press & Media

RMDM Group is a UK-based one-stop-shop for cancer diagnostics, prevention and treatment.

We use ground-breaking technology to provide healthcare partners worldwide with non-invasive, low cost and highly accurate early intervention diagnostic tools.

Established in 2017, RMDM is founded on the principles of the pioneering work of Dr Johannes Coy, who discovered the TKTL1 gene. Our purpose is to harness the power of cutting-edge research and technology to provide practical and affordable interventions to support health and wellbeing, focusing particularly on diagnostics and metabolism. The revolutionary PanTum Detect test is one such example.

Through our commitment to rigorous research and scientific collaboration, we work to translate evidence into practice in a way that positively disrupts the health and wellbeing industry.

Multimedia

PreviousNext
PreviousNext

RMDM Group in the News

Health Tech Digital

Lifesaving cancer diagnostic technology ready to launch in UK

Read More

Med-Tech Innovation

Blood test that detects all cancers to launch in UK

Read More

TotalHealth

Blood screening test for any cancer – PanTum Detect

Read More

Downloads

Dr Johannes Coy Q&A

Download